Company Profile

Hebei Guogao Biotechnology Co.，Ltd. is a modern IVD enterprise integrating R & D, production and sales. It is mainly committed to the development and innovation of in vitro diagnostic reagent bedside rapid test (POCT) products, aiming to create a "mobile micro laboratory".

The company was officially established on March 30, 2015. It is located in Baoding high tech Development Zone, Hebei Province, with convenient transportation and beautiful environment. It has modern laboratories and production lines. The total area of the enterprise is about 2000 ㎡, including 350 ㎡ purification plant, 150 ㎡ inspection room, 380 ㎡ R & D room, 600 ㎡ warehouse and 520 ㎡ office area.

The company has strong scientific research and technical force. Led by Professor Ma Yunguo, a national famous immunology expert and doctoral supervisor, the company has established a scientific research team that can bear hardships, specialize in research and innovation, and established three R & D departments, including 25 R & D personnel with graduate education.

The company has established advanced scientific management mode and perfect quality management system. In October 2015, the company began to implement YY / t0287idtiso13485 quality management system, and established ELISA reagent R & D laboratory and production line. It passed the medical device registration quality system inspection of Hebei food and Drug Administration in August 2017 and January 2018 respectively. In March 2018, it obtained the medical device registration certificate of human lipoprotein associated phospholipase (Lp-PLA2) assay kit and human N-terminal brain natriuretic peptide precursor (NT proBNP) assay kit, and obtained the medical device production license in April 2018. In order to meet the market demand and avoid the high cost and complexity of cold chain transportation, the company built a new fluorescence immunochromatography reagent R & D laboratory and production line in 2017, and approved more than 50 projects. In January 2020, the company obtained seven product registration certificates: Lp-PLA2, NT proBNP, CK-MB, myo, PCT, CRP β- HCG。 In September 2021, the registration certificates of 10 products were obtained again: cTnI / CK-MB / H-FABP, cTnI / CK-MB / myo, FSH, SAA, H-FABP, PAPP-A, IL-6, PCT / CRP, PCT / IL-6 and PGI / II. There are five types of dry-type fluorescence immunoanalyzer, mainly including: single channel model, multi-channel model, fully automatic model, multi card model and handheld model. It has been widely used in the market and won a good reputation.

The development of the company is changing with each passing day. At the same time, the company should spare no effort to seize the opportunities and challenges brought by the rapid development of biotechnology, continue to explore and innovate, strive for the development of medical diagnosis and medical cause in China, and make due contributions.

High and new technology based on the market, high-quality service and return to the society